A Causal Association Between Drug Use and Cognitive Impairment: A Two‐Sample Mendelian Randomization Study

Observational studies have suggested a link between certain drugs and cognitive impairment. In this study, a two‐sample Mendelian randomization (MR) approach was used to investigate the causal relationship between drug use and different types of dementia.

• Publication year

  2025

• Venue

  Brain and Behavior

• Publication date

  2025-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/brb3.71057PMID 41220200PMCID 12606049
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multimarker Cerebral Small Vessel Disease Score and Risk of Incident Dementia in the Framingham Heart Study

  2025cited by this paper
• A Causal Association Between Drug Use and Cognitive Impairment: A Two‐Sample Mendelian Randomization Study

  2025cited by this paper
• Can Changes in Financial Performance Be Used in the Diagnosis of Neurocognitive Disorders? A Systematic Review of Findings from Greece

  2024cited by this paper
• Perception and Identification of Behavioral and Psychological Symptoms of Dementia (BPSD) in China Medical Community

  2024cited by this paper
• Can machine learning assist us in the classification of older patients suffering from dementia based on classic neuropsychological tests and a new financial capacity test performance?

  2024cited by this paper
• Statins and risks of dementia among patients with heart failure: a population-based retrospective cohort study in Hong Kong

  2024cited by this paper
• The relation between cognitive functioning and activities of daily living in normal aging, mild cognitive impairment, and dementia: a meta-analysis

  2024cited by this paper
• Exploring the Therapeutic Effects of Multifunctional N-Salicylic Acid Tryptamine Derivative against Parkinson’s Disease

  2023cited by this paper
• Dementia prevention: the Mendelian randomisation perspective

  2023cited by this paper
• The effects of synthetic glucocorticoid treatment for inflammatory disease on brain structure, function, and dementia outcomes: A systematic review.

  2022cited by this paper
• Dementia is a Serious Disorder of Memory and other Intellectual Abilities

  2022cited by this paper
• Oral Anticoagulants and the Risk of Dementia in Patients With Nonvalvular Atrial Fibrillation

  2022cited by this paper
• No Genetic Causal Association Between Periodontitis and Arthritis: A Bidirectional Two-Sample Mendelian Randomization Analysis

  2022cited by this paper
• Mendelian randomization

  2022cited by this paper
• Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration

  2021cited by this paper
• Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture

  2021cited by this paper
• HIGH-SENSITIVITY CARDIAC TROPONIN T FOR THE DETECTION OF MYOCARDIAL INJURY AND RISK STRATIFICATION IN COVID-19

  2021cited by this paper
• α-Synuclein-mediated neurodegeneration in Dementia with Lewy bodies: the pathobiology of a paradox

  2021cited by this paper
• Effectiveness of sorting tests for detecting cognitive decline in older adults with dementia and other common neurodegenerative disorders: a meta-analysis.

  2020cited by this paper
• Oral anticoagulants and risk of dementia: A systematic review and meta‐analysis of observational studies and randomized controlled trials

  2019cited by this paper
• Causes and Patterns of Dementia: An Update in the Era of Redefining Alzheimer's Disease.

  2019cited by this paper
• A Comprehensive Update on Treatment of Dementia

  2019cited by this paper
• Genome-wide association study of medication-use and associated disease in the UK Biobank

  2019cited by this paper
• Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals

  2018cited by this paper
• Effects of Plasma Lipids and Statins on Cognitive Function

  2018cited by this paper
• Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases

  2018influential reference
• Anticholinergic drugs and risk of dementia: case-control study

  2018cited by this paper
• Increased All-Cause Mortality by Antipsychotic Drugs: Updated Review and Meta-Analysis in Dementia and General Mental Health Care

  2018cited by this paper
• Autoimmunity and Frontotemporal Dementia.

  2018cited by this paper
• Improving the visualization, interpretation and analysis of two-sample summary data Mendelian randomization via the Radial plot and Radial regression

  2018influential reference
• Which Risk Factors Causally Influence Dementia? A Systematic Review of Mendelian Randomization Studies

  2018cited by this paper
• Dehydration Impairs Cognitive Performance: A Meta-analysis

  2018cited by this paper
• Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians

  2018cited by this paper
• The pathology and pathophysiology of vascular dementia.

  2017cited by this paper
• Sensitivity Analyses for Robust Causal Inference from Mendelian Randomization Analyses with Multiple Genetic Variants

  2016cited by this paper
• The neuropathology and cerebrovascular mechanisms of dementia

  2016cited by this paper
• Lewy Body Dementias: Dementia With Lewy Bodies and Parkinson Disease Dementia

  2016cited by this paper
• Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator

  2016cited by this paper
• Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression

  2015influential reference
• The Benzodiazepine–Dementia Disorders Link: Current State of Knowledge

  2015cited by this paper
• Clinical Use of Diuretics in Heart Failure, Cirrhosis, and Nephrotic Syndrome

  2015cited by this paper
• The importance of detecting and managing comorbidities in people with dementia?

  2014cited by this paper
• Global estimates of the prevalence of diabetes for 2010 and 2030.

  2010cited by this paper
• Statins: mechanisms of neuroprotection.

  2009cited by this paper
• Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study

  2008cited by this paper
• Non‐steroidal anti‐inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action

  2004cited by this paper
• Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors

  2003cited by this paper
• Thyroid hormones, brain function and cognition: a brief review.

  2002cited by this paper
• Antihistamine Agent Dimebon As a Novel Neuroprotector and a Cognition Enhancer

  2001cited by this paper
• The effects of antihistamines on cognition and performance.

  2000cited by this paper
• The medical community.

  1993cited by this paper

• A Causal Association Between Drug Use and Cognitive Impairment: A Two‐Sample Mendelian Randomization Study

  2025cites this paper